Seeing is Understanding: Best Practices for Visualizing Nonclinical Study Data
SEND data visualization: best practices for visualizing nonclinical study data to reveal trends, spot outliers,…
Certara2026 年 2 月 2 日
SEND V4.0 – What to Expect and When to Expect It
2025 年 4 月 24 日 As the Standard for Exchange of Nonclinical Data (SEND) continues to evolve…
Certara2025 年 4 月 24 日
Visualizing SEND Data: Why and How
Senior Director, Product Management Peggy is the Customer Success lead for SEND Explorer. She has…
Certara2025 年 4 月 21 日
Best Practices for Visualization of Nonclinical Study Data in SEND Format (and Beyond)
Thank you for registering for our webinar, Best Practices for Visualization of Nonclinical Study Data…
Certara2025 年 4 月 15 日
Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis
2025 年 2 月 24 日 Efficient drug development relies on informed decision-making. For toxicologists, having timely access…
Certara2025 年 2 月 24 日
The Benefits of Real-Time Nonclinical Safety Data Analysis
Learn how SEND Explorer software helps nonclinical drug developers streamline performing real-time toxicology assessments of…
Certara2025 年 1 月 27 日
CDISC SEND Updates Nonclinical Drug Developers Need to Know
In this blog, Peggy Zorn explores updates to the Standard for Exchange of Nonclinical Data…
Certara2024 年 12 月 3 日
Transforming Non-clinical Drug Development with SEND Explorer
Since 1999, Genmab has been developing therapeutic antibodies and antibody-drug conjugates (ADCs) for treating cancer.…
Certara2024 年 7 月 8 日
